Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients

The Breast : Official Journal of the European Society of Mastology
Florian EbnerM Blettner

Abstract

The tumor biology of older breast cancer patients (oBCP) is usually less aggressive, however applied adjuvant treatment is often less potent resulting in an impaired disease free survival and overall survival in this group. This study tries to answer the following questions for the biological subtypes of oBCP (70+ y): Between 1992 and 2008 the BRENDA ('BRENDA' = quality of BREast caNcer care unDer evidence-bAsed guidelines) study group recorded medical data of 17 participating certified breast cancer centers in Germany. We performed a retrospective multi-center database analysis of 5632 patient records. Guideline-adherent-treatment (GL+) of oBCP(n = 1918) was compared to GL+ of yBCP(n = 3714). OBCP were more likely to have hormone receptor positive (HR+) and HER2neu negative (HER2-) breast cancer (77.5% vs 74.5%). The rate of GL- was significantly different (p < 0.001) between the age groups and the biological subgroups (yBCP vs oBCP: 21.8%vs38.8% (HR+/HER2-); 30.6%vs49.7% (HR+/HER2+); 23.6%vs69.5% (HR-/HER2+); 31.4%vs67.8% (TNBC)). The survival parameters for HR+/HER2- and TNBC were significantly worse in case of GL- regarding chemotherapy, and if applicable endocrine therapy. A similar association only existed in HR-/HER2+ tu...Continue Reading

References

Jul 1, 1996·The British Journal of Surgery·A J SandisonP A Jones
Aug 30, 2000·Journal of Surgical Oncology·J de CsepelC Gajdos
Aug 13, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine BouchardyGeorges Vlastos
Sep 27, 2003·Journal of the American Geriatrics Society·Elisabetta RapitiJohn Kurtz
Sep 3, 2004·The New England Journal of Medicine·Kevin S HughesUNKNOWN Eastern Cooperative Oncology Group
Aug 24, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roman RouzierLajos Pusztai
Feb 21, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianne KyndiUNKNOWN Danish Breast Cancer Cooperative Group
Aug 26, 2009·Women's Health·Sumanta Kumar Pal, Joanne Mortimer
Oct 15, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K HanckeR Kreienberg
Apr 7, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ann H PartridgeHyman Muss
May 11, 2010·The Breast : Official Journal of the European Society of Mastology·Paul S CraftNoel Tait
Jun 30, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Dawn L HershmanAlfred I Neugut
Jul 27, 2010·Critical Reviews in Oncology/hematology·Barbara L Van LeeuwenUNKNOWN Department of Surgical Oncology, MD Anderson Cancer Center
Feb 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alice B KornblithHyman B Muss
Jun 3, 2011·Breast Care·Michael GnantChristoph Thomssen
Jun 29, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A GoldhirschUNKNOWN Panel members
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R WoltersA Wöckel
Aug 13, 2011·Breast Cancer Research and Treatment·Yahong WangYun Niu
Feb 2, 2012·International Journal of Breast Cancer·Hua WangAlan R Go
Aug 29, 2012·International Journal of Surgical Oncology·John M BrooksNancy L Keating
Jan 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A RingL J Fallowfield
Feb 1, 2013·Journal of Cancer Epidemiology·Manmeet Kaur MalikRachel Belfer
Feb 9, 2013·The British Journal of Radiology·F E LanglandsL Smith
Apr 2, 2013·The Breast : Official Journal of the European Society of Mastology·Uwe GüthMarcus Vetter
Feb 14, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Carol SweeneyBette J Caan
Feb 14, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Bette J CaanPhilip S Bernard

❮ Previous
Next ❯

Citations

May 8, 2020·Breast Cancer Research and Treatment·Ena Niño de GuzmánIgnacio Ricci-Cabello
Sep 18, 2015·Deutsches Ärzteblatt International·Carolin Nestle-Krämling, Christoph Andree

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.